COCH vs. CLGN, RBOT, MLSS, LFWD, INGN, NTRB, SMTI, FONR, BRNS, and CLRB
Should you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include CollPlant Biotechnologies (CLGN), Vicarious Surgical (RBOT), Milestone Scientific (MLSS), ReWalk Robotics (LFWD), Inogen (INGN), Nutriband (NTRB), Sanara MedTech (SMTI), FONAR (FONR), Barinthus Biotherapeutics (BRNS), and Cellectar Biosciences (CLRB). These companies are all part of the "medical" sector.
Envoy Medical (NASDAQ:COCH) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, community ranking, valuation, risk, media sentiment and analyst recommendations.
Envoy Medical has a beta of 2.68, meaning that its share price is 168% more volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500.
Envoy Medical currently has a consensus target price of $6.00, indicating a potential upside of 15.83%. CollPlant Biotechnologies has a consensus target price of $11.00, indicating a potential upside of 86.76%. Given CollPlant Biotechnologies' higher probable upside, analysts plainly believe CollPlant Biotechnologies is more favorable than Envoy Medical.
CollPlant Biotechnologies has higher revenue and earnings than Envoy Medical.
8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. 0.7% of Envoy Medical shares are owned by insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
CollPlant Biotechnologies received 130 more outperform votes than Envoy Medical when rated by MarketBeat users. However, 100.00% of users gave Envoy Medical an outperform vote while only 58.59% of users gave CollPlant Biotechnologies an outperform vote.
Envoy Medical has a net margin of 0.00% compared to CollPlant Biotechnologies' net margin of -64.05%. Envoy Medical's return on equity of 0.00% beat CollPlant Biotechnologies' return on equity.
In the previous week, Envoy Medical had 3 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 5 mentions for Envoy Medical and 2 mentions for CollPlant Biotechnologies. CollPlant Biotechnologies' average media sentiment score of 0.75 beat Envoy Medical's score of 0.43 indicating that CollPlant Biotechnologies is being referred to more favorably in the news media.
Summary
CollPlant Biotechnologies beats Envoy Medical on 8 of the 15 factors compared between the two stocks.
Get Envoy Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Envoy Medical Competitors List
Related Companies and Tools
